These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 20384386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).
    Bönner G, Landers B, Bramlage P.
    Vasc Health Risk Manag; 2011; 7():85-95. PubMed ID: 21415922
    [Abstract] [Full Text] [Related]

  • 3. Candesartan cilexetil 32 mg/hydrochlorothiazide 25 mg in unselected patients with high or very high cardiovascular risk: efficacy, safety, and metabolic impact.
    Bramlage P, Buhck H, Zemmrich C.
    Clin Drug Investig; 2014 Apr; 34(4):241-9. PubMed ID: 24482018
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
    Lee HY, Hong BK, Chung WJ, Lee BK, Lee SH, Jeon DW, Ahn YK, Kim D, Park CK, Kim SH, Jung HO, Kim BO, Choi D.
    Clin Ther; 2011 Aug; 33(8):1043-56. PubMed ID: 21831438
    [Abstract] [Full Text] [Related]

  • 6. Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.
    Mengden T, Uen S, Bramlage P.
    Vasc Health Risk Manag; 2009 Aug; 5():1043-58. PubMed ID: 20057897
    [Abstract] [Full Text] [Related]

  • 7. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
    Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL.
    Am J Cardiol; 1999 Aug 01; 84(3):289-93. PubMed ID: 10496437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with Candesartan/HCTZ].
    Bramlage P, Schönrock E, Odoj P, Wolf WP, Funken C.
    MMW Fortschr Med; 2008 Jan 17; 149 Suppl 4():172-81. PubMed ID: 18402243
    [Abstract] [Full Text] [Related]

  • 10. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B, Gerwe M, Braun M, Funken C.
    Arzneimittelforschung; 2005 Jan 17; 55(9):505-13. PubMed ID: 16229114
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide.
    Neldam S, Forsén B, Multicentre Study Group.
    Drugs Aging; 2001 Jan 17; 18(3):225-32. PubMed ID: 11302289
    [Abstract] [Full Text] [Related]

  • 12. A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy.
    Campbell M, Sonkodi S, Soucek M, Wiecek A.
    Clin Exp Hypertens; 2001 May 17; 23(4):345-55. PubMed ID: 11349825
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
    Fogari R, Mugellini A, Derosa G, CANDIA (CANdesartan and DIuretic vs. Amlodipine in hypertensive patients) Study Group.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep 17; 8(3):139-44. PubMed ID: 17907102
    [Abstract] [Full Text] [Related]

  • 14. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB, Jarvis B.
    Drugs; 2002 Sep 17; 62(5):787-816. PubMed ID: 11929332
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide.
    Ohma KP, Milon H, Valnes K.
    Blood Press; 2000 Sep 17; 9(4):214-20. PubMed ID: 11055474
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N.
    Clin Ther; 2012 Apr 17; 34(4):838-48. PubMed ID: 22440192
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
    McInnes GT, O'Kane KP, Istad H, Keinänen-Kiukaanniemi S, Van Mierlo HF.
    J Hum Hypertens; 2000 Apr 17; 14(4):263-9. PubMed ID: 10805052
    [Abstract] [Full Text] [Related]

  • 18. Candesartan plus hydrochlorothiazide: an overview of its use and efficacy.
    Mugellini A, Nieswandt V.
    Expert Opin Pharmacother; 2012 Dec 17; 13(18):2699-709. PubMed ID: 23170938
    [Abstract] [Full Text] [Related]

  • 19. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
    Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS.
    Blood Press; 1996 Jan 17; 5(1):32-40. PubMed ID: 8777471
    [Abstract] [Full Text] [Related]

  • 20. Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon.
    Mengden T, Hübner R, Bramlage P.
    Vasc Health Risk Manag; 2011 Jan 17; 7():761-9. PubMed ID: 22241950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.